Study Finds Ivermectin ‘Did Not Prevent’ Severe COVID-19, but Doctors Alliance Calls It ‘Misleading’

Ivermectin tablets packaged for human use. Natasha Holt/The Epoch Times

A peer-reviewed study in which researchers concluded that ivermectin treatment during early COVID-19 “did not prevent” severe disease in high-risk patients has been criticized by an alliance of doctors for being “misleading.”

In the open-label randomized clinical trial, also referred to as the “The I-TECH Randomized Clinical Trial,” published in the JAMA Internal Medicine journal on Feb. 18, researchers said their findings “do not support the use of ivermectin for patients with COVID-19.”